Posts Tagged ‘PRP’

New study Demonstrates Platelet-Rich Plasma (PRP) May Help Treat a Particular Type of Hair Loss, Alopecia Areata

Friday, May 17th, 2013 by Steven Sampson D.O.

alopecia areata 200x300 New study Demonstrates Platelet Rich Plasma (PRP) May Help Treat a Particular Type of Hair Loss, Alopecia AreataAlopecia Areata (AA) is an auto-immune condition in which the body’s immune system, whose normal function is to fight infection and disease, attacks itself inappropriately. In AA, the result of this auto-immune activity is inflammation that leads to hair loss. Unfortunately, AA currently has very few treatment options. Platelet-rich plasma (PRP) has been established as a safe and cost-effective source of growth factors that stimulate cells to repair tissue. A study was recently conducted to evaluate whether PRP could potentially be used to treat AA. Forty-five patients received one of three different treatments – either PRP, an anti-inflammatory steroid, or nothing at all to serve as a placebo. On the other half of their heads they received no treatment whatsoever. Each patient received a total of three treatments one month apart from each other. Results showed that PRP was found to significantly increase hair regrowth and decrease hair loss along with burning/itching sensation when compared with steroid  or placebo. No side effects were noted during treatment. This pilot study suggests that PRP may serve as a safe and effective treatment option for AA. The Orthohealing Center is constantly involved in new research to develop state-of-the-art techniques for treating patients with a variety of health issues, including PRP for joint and tendon and spine injuries. PRP has implications for many conditions to potentially regulate inflammation and stimulate healing.

avatar

Steven Sampson D.O.

Founder of the Orthohealing Center, Dr. Sampson is a recognized expert on orthobiologics and regenerative medicine. He lectures internationally and spearheads OHC’s clinical research efforts. Dr. Sampson is a Clinical Instructor of Medicine at The David Geffen School of Medicine at UCLA, and is a Clinical Assistant Professor of Physical Medicine & Rehabilitation, Western University of Health Sciences.

Study finds PRP to be among the most effective treatments for chronic heel pain in adults

Friday, May 3rd, 2013 by Steven Sampson D.O.

Untitled2 300x283 Study finds PRP to be among the most effective treatments for chronic heel pain in adultsA recent study suggests that PRP is one of the most effective treatments for chronic heel pain. Plantar fasciitis is a musculoskeletal disorder and a common reason for heel pain in adults. A whooping 2 million Americans are affected by heel pain annually. The condition has a higher occurrence rate among athletes and sedentary individuals. The study aims to find out the more effective treatments toaddress moderate and severe plantar fasciitis conditions, through a comparison between the effectiveness of PRP and corticosteroid injection. The treatment involves two injection treatments for chronic heel pain. Based on clinical and radiographic outcomes, it is found that PRP is indeed the more promising solution to address chronic heel pain in adults. The Orthohealing Center provides PRP options that can potentially alleviate chronic heel pain in patients.

avatar

Steven Sampson D.O.

Founder of the Orthohealing Center, Dr. Sampson is a recognized expert on orthobiologics and regenerative medicine. He lectures internationally and spearheads OHC’s clinical research efforts. Dr. Sampson is a Clinical Instructor of Medicine at The David Geffen School of Medicine at UCLA, and is a Clinical Assistant Professor of Physical Medicine & Rehabilitation, Western University of Health Sciences.

PRP Platelet Rich Plasma gaining popularity with mainstream orthopedics: Journal of Bone & Joint Surgery (JBJS) offering new webinar.

Tuesday, April 30th, 2013 by Steven Sampson D.O.

JBJS logo PRP Platelet Rich Plasma gaining popularity with mainstream orthopedics: Journal of Bone & Joint Surgery (JBJS) offering new webinar.Evidence of the growing interest to understand the science and evidence behind PRP, a major peer reviewed medical journal JBJS, will be offering a webinar to educate physicians. While PRP is by no means a panacea, some conditions including tennis elbow and joint osteoarthritis may hold the most promise. More natural based non-surgical alternatives are needed to address the growing numbers of people with pain. Further controlled  trials are needed to better understand which patients and injuries may be optimal candidates. The field of Orthobiologics is undergoing a renaissance, evidenced by increased awareness in the medical community. In June we will be hosting over 100 leading physicians here in Los Angeles from around the globe www.prpseminar.com to discuss the latest innovations in biologic based medicine.

avatar

Steven Sampson D.O.

Founder of the Orthohealing Center, Dr. Sampson is a recognized expert on orthobiologics and regenerative medicine. He lectures internationally and spearheads OHC’s clinical research efforts. Dr. Sampson is a Clinical Instructor of Medicine at The David Geffen School of Medicine at UCLA, and is a Clinical Assistant Professor of Physical Medicine & Rehabilitation, Western University of Health Sciences.

Hospital for Special Surgery: Platelet-rich Plasma (PRP) therapy as a treatment for Knee Osteoarthritis

Wednesday, April 17th, 2013 by Steven Sampson D.O.

PRP Study 3 300x145 Hospital for Special Surgery: Platelet rich Plasma (PRP) therapy as a treatment for Knee OsteoarthritisA new study, soon to be printed in the Clinical Journal of Sports Medicine, supports the potential role of Platelet-rich Plasma (PRP) injection as a therapy for knee osteoarthritis. Hospital of Special Surgery, HSS conducted this research on fifteen patients with early osteoarthritis. Each patient received a PRP injection and was subsequently monitored for one year. Clinical assessments were made at baseline (prior to therapy), 1 week, and at 1, 3, and 12 months. In addition, magnetic resonance imaging (MRI) was performed at baseline and again at one-year post injection. This served as an objective measure, which had never been done in any previous PRP study. Research has shown that patients with osteoarthritis can lose about 5% of knee cartilage (tissue that protects joint) per year. However, in this study 73% of patients had no loss of cartilage at the end of one year. Also, patients reported pain reduction and improved function with decreased stiffness. Although this is a case series with 15 patients, it gives researchers confidence to conduct a randomized, controlled trial in the future.

avatar

Steven Sampson D.O.

Founder of the Orthohealing Center, Dr. Sampson is a recognized expert on orthobiologics and regenerative medicine. He lectures internationally and spearheads OHC’s clinical research efforts. Dr. Sampson is a Clinical Instructor of Medicine at The David Geffen School of Medicine at UCLA, and is a Clinical Assistant Professor of Physical Medicine & Rehabilitation, Western University of Health Sciences.

European Journal of Orthopaedic Surgery & Traumatology: Early knee Osteoarthritis treated effectively with Platelet-rich plasma (PRP) injections

Tuesday, April 2nd, 2013 by Steven Sampson D.O.

knee 3 300x285 European Journal of Orthopaedic Surgery & Traumatology: Early knee Osteoarthritis treated effectively with Platelet rich plasma (PRP) injectionsA recent study from Korea evaluates how the extent of joint damage in knee osteoarthritis affects the potential of platelet-rich plasma (PRP) injection. Sixty-five patients with knee osteoarthritis received platelet-rich plasma injection and were subsequently followed-up at 1,3,6,9, and 12 months.

Patients reported pain relief and functional improvement 6 months post-injection but also documented relapsed pain 8.8 months after the procedure. Additionally, patients that developed further degeneration of the joint experienced relapsed pain faster than the rest. Also, a negative correlation was witnessed between a patient’s age and PRP injection’s potential in improving patient’s pain and function. In conclusion, platelet-rich plasma therapy can be used in treating early osteoarthritis but degeneration of the joint and increasing age decreases the potential benefit of PRP. This supports our current understanding that PRP works best in knee arthritis when intervention is early in more active individuals. For more advanced arthritis, BMC Bone Marrow Concentrate  is the next generation biologic injection with promise before undergoing total joint replacement.

avatar

Steven Sampson D.O.

Founder of the Orthohealing Center, Dr. Sampson is a recognized expert on orthobiologics and regenerative medicine. He lectures internationally and spearheads OHC’s clinical research efforts. Dr. Sampson is a Clinical Instructor of Medicine at The David Geffen School of Medicine at UCLA, and is a Clinical Assistant Professor of Physical Medicine & Rehabilitation, Western University of Health Sciences.

New Research from Orthohealing Center’s Dr Steven Sampson & Dr Danielle Aufiero on the world’s largest placebo controlled PRP trial on tennis elbow, presented at the AAOS in Chicago IL.

Thursday, March 28th, 2013 by Steven Sampson D.O.

Platelet-Rich Plasma Significantly Improves Clinical Outcomes in Patients with Chronic Tennis Elbow:
sampson mishra pic 225x300 New Research from Orthohealing Center’s Dr Steven Sampson & Dr Danielle Aufiero on the world’s largest placebo controlled PRP trial on tennis elbow, presented at the AAOS in Chicago IL.A Double-Blind, Prospective, Multicenter, Controlled Trial of 230 Patients

Allan K. Mishra,  MD; Nebojsa V. Skrepnik, MD, PhD; Scott G. Edwards, MD; Grant L. Jones, MD; Steven Sampson, DO; Doug A. Vermillion, MD; Matthew L. Ramsey, MD; David C. Karli, MD, MBA; Arthur C. Rettig, MD

Dr Steven Sampson travelled to Chicago for the world’s largest gathering of orthopaedic surgeons (AAOS) as a Principal Investigator in the world’s largest placebo controlled PRP trial.  The study was a randomized, double-blind, multi-center controlled trial of 230 patients.  Patients received needling of their elbow tendons with and without PRP.  At 24 weeks the PRP patients reports a 71.5% improvement in their pain compared to 56.1 in the control group. (P = 0.027)  Patients treated with PRP also had less elbow tenderness at each follow up point. Overall, 84% of the PRP patients were successfully treated compared to 68.3% of the control group. (P = 0.012)

84% of patients with chronic tennis elbow who had failed other non-operative treatments were successfully treated using platelet-rich plasma (PRP) in a large randomized trial.

There are now over 340 patients who have been treated confirming the value of PRP as a treatment for chronic tennis elbow.  Importantly, there is also a decade long experience using PRP with an excellent safety profile.  PRP with this newly released data can now be confidently used for chronic tennis elbow patients prior to considering surgical intervention.

The results will be presented by Dr. Allan K. Mishra at TOBI 4th Annual PRP & Regenerative Medicine Symposium, June 7-8, 2013 in Los Angeles. Event details and registration online at www.prpseminar.com.

This study took 6 years to produce and validate the findings we have seen in our clinics for years. More and more robust trials are coming to further clarify the role for PRP and regenerative procedures in the near future.

View Abstract: PRPseminar.com

For more of the latest PRP research and clinical experience, plus networking with field leaders, attend The Orthobiologic Institute (TOBI) 4th Annual PRP & Regenerative Medicine Symposium, June 7-8, 2013 in Los Angeles. Details and registration at www.prpseminar.com. Early Rates through March 31st – Register Now!

avatar

Steven Sampson D.O.

Founder of the Orthohealing Center, Dr. Sampson is a recognized expert on orthobiologics and regenerative medicine. He lectures internationally and spearheads OHC’s clinical research efforts. Dr. Sampson is a Clinical Instructor of Medicine at The David Geffen School of Medicine at UCLA, and is a Clinical Assistant Professor of Physical Medicine & Rehabilitation, Western University of Health Sciences.

New Research from American Academy of Orthopaedic Surgeons finds PRP Platelet Rich Plasma more effective than cortisone injection with a 16x less risk of requiring surgery.

Thursday, March 28th, 2013 by Steven Sampson D.O.

prp 2 New Research from American Academy of Orthopaedic Surgeons finds PRP Platelet Rich Plasma more effective than cortisone injection with a 16x less risk of requiring surgery.Award winning research was presented from Ireland showing that patients with rotator cuff tendinopathy(shoulder pain) had dramatically better results with PRP compared to steroid (cortisone)shots. 204 patients were followed for 1 year. According to the AAOS: At 12-month follow-up, patients who received a series of PRP injections were 16 times less likely to have undergone surgical intervention than patients who received corticosteroid injections,” the authors said. The authors concluded that PRP injections are a clinically safe and cost-effective treatment alternative to corticosteroid injections for RCT pain. Steroid injections are known to damage tendons and may promote cell death. PRP may represent a healthier alternative while improving pain and reducing the need for surgery. At the Orthohealing Center, we have been using PRP for rotator cuff tears and tendinopathy for 6 years with very encouraging results, although more trials are needed to better understand the mechanisms of pain reduction and improved function.

avatar

Steven Sampson D.O.

Founder of the Orthohealing Center, Dr. Sampson is a recognized expert on orthobiologics and regenerative medicine. He lectures internationally and spearheads OHC’s clinical research efforts. Dr. Sampson is a Clinical Instructor of Medicine at The David Geffen School of Medicine at UCLA, and is a Clinical Assistant Professor of Physical Medicine & Rehabilitation, Western University of Health Sciences.

New research from Italy shows PRP Platelet Rich Plasma effective for Knee Osteoarthritis with 2 year follow up.

Wednesday, March 27th, 2013 by Steven Sampson D.O.

osr logo New research from Italy shows  PRP Platelet Rich Plasma effective for Knee Osteoarthritis with 2 year follow up.Our TOBI Faculty & colleagues Alberto Gobbi MD, Georgios Karnatzikos MD from Milan, Italy presented research at the world’s largest gathering of Orthopaedic Surgeons in Chicago Il last wk, the AAOS.

This study shows that PRP intra-articular knee injections are effective both in operated and non-operated arthritic knees and can act as a preventive agent of OA, by diminishing pain and improving symptoms and quality of life. Patients who repeated PRP treatment preserved a better clinical outcome, indicating that PRP injections can provide a better outcome when repeated. This study builds on our pilot clinical trial for knee arthritis with PRP that showed significant improvement at 1 year follow up. More and more studies are emerging that demonstrate the cost effectiveness and therapeutic benefit of PRP for arthritis.

avatar

Steven Sampson D.O.

Founder of the Orthohealing Center, Dr. Sampson is a recognized expert on orthobiologics and regenerative medicine. He lectures internationally and spearheads OHC’s clinical research efforts. Dr. Sampson is a Clinical Instructor of Medicine at The David Geffen School of Medicine at UCLA, and is a Clinical Assistant Professor of Physical Medicine & Rehabilitation, Western University of Health Sciences.

Orthohealing Center’s Knee Osteoarthritis PRP Platelet Rich Plasma Research Referenced at the 9th Middle East Orthopaedic Conference in Dubai.

Wednesday, March 27th, 2013 by Steven Sampson D.O.

Nunez pic e1364427241945 224x300 Orthohealing Center’s Knee Osteoarthritis PRP Platelet Rich Plasma Research Referenced at the 9th Middle East Orthopaedic Conference in Dubai.Our colleague from Argentina, Dr Gerardo Marcelo Nunez recently attended the 9th Middle East Orthopedic Conference in Dubai.

Cutting edge research was presented on PRP Platelet Rich Plasma for knee osteoarthritis. The Orthohealing Center’s pilot trial was referenced multiple times at the conference, serving as a platform for larger clinical trials that are now emerging. A worldwide collaboration is occurring as physicians are recognizing the need for more innovative and cost effective treatments as alternatives to surgery. Further research ius needed to best determine who may be an ideal candidate for PRP or BMC injection therapy.

avatar

Steven Sampson D.O.

Founder of the Orthohealing Center, Dr. Sampson is a recognized expert on orthobiologics and regenerative medicine. He lectures internationally and spearheads OHC’s clinical research efforts. Dr. Sampson is a Clinical Instructor of Medicine at The David Geffen School of Medicine at UCLA, and is a Clinical Assistant Professor of Physical Medicine & Rehabilitation, Western University of Health Sciences.

Dr Steven Sampson, Orthohealing Center (Los Angeles) visits Dr David Karli, Steadman Clinic (Vail ) for best practices in BMC Bone Marrow Concentrate and PRP Platelet Rich Plasma.

Monday, February 18th, 2013 by Steven Sampson D.O.

Dr KArli e1361215588497 225x300 Dr Steven Sampson, Orthohealing Center (Los Angeles) visits Dr David Karli, Steadman Clinic  (Vail ) for best practices in BMC Bone Marrow Concentrate and PRP Platelet Rich Plasma.Dr Steven Sampson was recently invited to visit Dr David Karli who trained at Harvard University & currently  works at the renowned Steadman Clinic in Vail Colorado.  Dr Karli is one of the pioneers in regenerative medicine and has been performing BMC on knee and hip osteoarthritis for nearly 2 years with encouraging results.  Interestingly, many of the surgeries there routinely include PRP intra-operatively to expedite recovery & healing. This biologic approach to surgery will likely spread across the country as more awareness catches on.   Both doctors shared protocols & ideas about the future of biologic medicine in orthopedics and sports medicine. Meetings like this advance our understanding of biologics and grows the community of enthusiastic physicians unsatisfied with the limited options presently available for joint pain and cartilage disorders. Dr Karli will be lecturing at Dr Sampson’s annual event in Los Angeles, The Orthobiologic Institute’s 4th annual prp & regenerative medicine symposium with cadaver lab, June 7-8, 2013.

avatar

Steven Sampson D.O.

Founder of the Orthohealing Center, Dr. Sampson is a recognized expert on orthobiologics and regenerative medicine. He lectures internationally and spearheads OHC’s clinical research efforts. Dr. Sampson is a Clinical Instructor of Medicine at The David Geffen School of Medicine at UCLA, and is a Clinical Assistant Professor of Physical Medicine & Rehabilitation, Western University of Health Sciences.